器官移植术后预防人巨细胞病毒感染研究进展
被引量：1
摘要
器官移植术后,有效免疫抑制药物的使用同时,出现人巨细胞病毒(hCMV)的机会感染,在巨细胞病毒(CMV)感染后再治疗较困难,并增加抗排异的难度。故如何有效的预防CMV感染尤为重要,能提高器官移植术后的生存率。现对目前有效预防CMV感染的方法作综述。
出处
《国外医学（外科学分册）》
2005年第4期304-307,共4页
Foreign Medical Sciences(section of Surgery)
参考文献15
-
1Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol, 2000, 13: 83-121.
-
2Temperton NJ. DNA vaccines against cytomegalovirus: current progress. Inter J Antimicrobial Angents, 2002, 19: 169-172.
-
3Bernstein DI, Schleiss MR, Berencsi K, et al. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B(gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J Infect Dis, 2002, 185(5): 686-690.
-
4BuenoJ, Ramil C, Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients. Pediatr Drugs, 2002, 4: 279-290.
-
5Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis, 2001, 32: 596-603.
-
6Taber DJ, Ashcraft E, Baillie GM, et al. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis, 2004, 6: 101-109.
-
7Ajit PL, Ramasawamy B, Hyung WK, et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxia. Transplantation, 2004, 78: 1390-1396.
-
8Samuel C, Nell SL, David PW, et al. Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patientwith autosomal-recessive severe combinedimmune deficiency.J Pediatr Hematol Oncol,2004,26:601 605.
-
9Singh N. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis, 2001, 32: 742-751.
-
10Florencia P, Robert HR. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipient. Curr Opin Infect Dis, 2004, 17: 357-361.
同被引文献2
-
1陈江华,茅幼英,何强,吴建永,吕蓉.术前巨细胞病毒感染对移植肾急性排斥的影响[J].中华肾脏病杂志,2005,21(4):223-226. 被引量：9
-
2梁思敏,吴小候,苟欣,刘航.肾移植围手术期检测CMV-PP65抗原的意义[J].第三军医大学学报,2005,27(18):1865-1867. 被引量：2
-
1白剑,肖漓,石炳毅.器官移植术后人巨细胞病毒感染的实验室诊断研究进展[J].中国误诊学杂志,2008,8(12):2791-2793. 被引量：9
-
2缪晓辉,向晓星.肝脏免疫耐受机制[J].肝脏,2001,6(2):119-120.
-
3秦学祥,李国斌.移植肾活检病理对基础抗排异方案指导的临床体会[J].中国卫生产业,2013,10(30):93-93.
-
4肖龙明,庞家瑜,何国友,霍伟堂,吴品林.镍钛合金支架管在尿道成形术中的应用[J].中国医师进修杂志（外科版）,2008,31(9):71-72.
-
5董盼盼,徐海燕.器官移植术后巨细胞病毒载量定量检测方法的研究进展[J].国际病毒学杂志,2014,21(2):88-91. 被引量：5
-
6薛珂.乳腺外科术后预防感染的护理难点和感染后抗生素使用[J].中国医学工程,2015,23(8):168-168. 被引量：3
-
7高继胜,王海涛.骨科创伤患者术后并发症的预防和治疗[J].中国实用医药,2016,11(36):70-72.
-
8肖扬名,施凯,罗敏华,孙颖,齐范.器官移植术后受者人巨细胞病毒的PCR检测[J].湖南医科大学学报,1996,21(2):120-122. 被引量：1
-
9刘爱民.低分子肝素在射频消融术后预防下肢静脉血栓中的应用观察[J].河北医药,2013,35(9):1368-1369. 被引量：5
-
10刘磊,刘作金.骨髓间充质干细胞诱导免疫耐受的研究进展[J].国际检验医学杂志,2013,34(18):2419-2422. 被引量：1
